1 |
Chen C, Liang T, Wu Q, Zhou Z, Zhang M, Feng D, Tao J, Si T, Cai M. Systems Pharmacology-Based Strategy to Investigate the Mechanism of Ruangan Lidan Decoction for Treatment of Hepatocellular Carcinoma. Comput Math Methods Med 2022;2022:2940654. [PMID: 36578460 DOI: 10.1155/2022/2940654] [Reference Citation Analysis]
|
2 |
Fang X, Zhang Y, Cao Y, Shan M, Song D, Ye C, Zhu D. Studies on Chemical Composition of Pueraria lobata and Its Anti-Tumor Mechanism. Molecules 2022;27:7253. [DOI: 10.3390/molecules27217253] [Reference Citation Analysis]
|
3 |
Wang S, Wu Y, Liu M, Zhao Q, Jian L. DHW-208, A Novel Phosphatidylinositol 3-Kinase (PI3K) Inhibitor, Has Anti-Hepatocellular Carcinoma Activity Through Promoting Apoptosis and Inhibiting Angiogenesis. Front Oncol 2022;12:955729. [DOI: 10.3389/fonc.2022.955729] [Reference Citation Analysis]
|
4 |
Yang H, Lei G, Sun F, Cheng J, Yan J, Zhang S, Yang P. Oncolytic Activity of a Chimeric Influenza A Virus Carrying a Human CTLA4 Antibody in Hepatocellular Carcinoma. Front Oncol 2022;12:875525. [PMID: 35494032 DOI: 10.3389/fonc.2022.875525] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
5 |
Wang Y, Song F, Zhang X, Yang C, Zhang J. Mitochondrial-Related Transcriptome Feature Correlates with Prognosis, Vascular Invasion, Tumor Microenvironment, and Treatment Response in Hepatocellular Carcinoma. Oxidative Medicine and Cellular Longevity 2022;2022:1-28. [DOI: 10.1155/2022/1592905] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
6 |
Liu J, Yang C, Huang XM, Lv PP, Yang YK, Zhao JN, Zhao SY, Sun WJ. Knockdown of FBI-1 Inhibits the Warburg Effect and Enhances the Sensitivity of Hepatocellular Carcinoma Cells to Molecular Targeted Agents via miR-3692/HIF-1α. Front Oncol 2021;11:796839. [PMID: 34869045 DOI: 10.3389/fonc.2021.796839] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
|